For full functionality of this site it is necessary to enable JavaScript.

Here are the instructions how to enable JavaScript in your web browser

ProEmpower

Doctor consulting a patient

Proempower

Pre-Commercial Procurement of innovative ICT for patient empowerment and self-management for patients with type 2 diabetes mellitus

Our vision

To improve detection of type II diabetes and treatment through person-centred and personalised care. To address the problems of patients; improve the knowledge on diabetes; support patients in communicating their treatment preferences to physicians and in leading healthier lifestyles. Lastly, we are striving to prevent the onset of diabetes and thus avoid complications.
Learn more

March 2018

Close of call for tender

Review of results and contracting best value for money suppliers

January 2018

Call for tender

Publishing a call for tender in the European Journal

May 2017

Open Market consultation

Regional and European events to engage in a dialogue with potential vendors.

Read more

ProEmpower PCP Phase One participants announced

Read more
Picture of an opened envelope

Subscribe to our newsletter today to stay up to date!

Subscribe now

Recent Tweets

  1. The evaluation of submissions is now over, here are the companies whose proposals for innovative ICT solutions for… t.co/JlEKN7mgYr

    46 days ago
  2. We are delighted to announce the names of the companies that have been awarded contracts for Phase 1 of the ProEmpo… t.co/w9Dn9Uz60L

    47 days ago
  3. Congratulations to the companies selected to continue to the next phase of ProEmpower PCP! Find out who they are: t.co/2kKQ9Zx36P

    47 days ago
Picture of four people sitting at the table

Open market Consultation

The procurers of ProEmpower would like to engage with vendors consulting their opinion on the state of the market and the envisaged ProEmpower system.

Learn more

Picture of a large interracial group of people

Who we are

We are procurers from four regions in Europe. We teamed up to procure a continuous diabetes management solution for our 12 Mil diabetes patients.

Who we are